Literature DB >> 27540007

Discovery of a proteinaceous cellular receptor for a norovirus.

Robert C Orchard1, Craig B Wilen1, John G Doench2, Megan T Baldridge1, Broc T McCune1, Ying-Chiang J Lee1, Sanghyun Lee1, Shondra M Pruett-Miller3, Christopher A Nelson1, Daved H Fremont1, Herbert W Virgin4.   

Abstract

Noroviruses (NoVs) are a leading cause of gastroenteritis globally, yet the host factors required for NoV infection are poorly understood. We identified host molecules that are essential for murine NoV (MNoV)-induced cell death, including CD300lf as a proteinaceous receptor. We found that CD300lf is essential for MNoV binding and replication in cell lines and primary cells. Additionally, Cd300lf(-/-) mice are resistant to MNoV infection. Expression of CD300lf in human cells breaks the species barrier that would otherwise restrict MNoV replication. The crystal structure of the CD300lf ectodomain reveals a potential ligand-binding cleft composed of residues that are critical for MNoV infection. Therefore, the presence of a proteinaceous receptor is the primary determinant of MNoV species tropism, whereas other components of cellular machinery required for NoV replication are conserved between humans and mice.
Copyright © 2016, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27540007      PMCID: PMC5484048          DOI: 10.1126/science.aaf1220

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  28 in total

1.  The crystal structure of the extracellular domain of the inhibitor receptor expressed on myeloid cells IREM-1.

Authors:  José Antonio Márquez; Elena Galfré; Florine Dupeux; David Flot; Oscar Moran; Nazzareno Dimasi
Journal:  J Mol Biol       Date:  2007-01-10       Impact factor: 5.469

2.  Cutting edge: mouse CD300f (CMRF-35-like molecule-1) recognizes outer membrane-exposed phosphatidylserine and can promote phagocytosis.

Authors:  Seung-Chul Choi; Venkateswara R Simhadri; Linjie Tian; Aleksandra Gil-Krzewska; Konrad Krzewski; Francisco Borrego; John E Coligan
Journal:  J Immunol       Date:  2011-08-24       Impact factor: 5.422

3.  Norwalk virus infection and disease is associated with ABO histo-blood group type.

Authors:  Anne M Hutson; Robert L Atmar; David Y Graham; Mary K Estes
Journal:  J Infect Dis       Date:  2002-04-16       Impact factor: 5.226

4.  Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity.

Authors:  Timothy J Nice; Megan T Baldridge; Broc T McCune; Jason M Norman; Helen M Lazear; Maxim Artyomov; Michael S Diamond; Herbert W Virgin
Journal:  Science       Date:  2014-11-27       Impact factor: 47.728

5.  Enteric bacteria promote human and mouse norovirus infection of B cells.

Authors:  Melissa K Jones; Makiko Watanabe; Shu Zhu; Christina L Graves; Lisa R Keyes; Katrina R Grau; Mariam B Gonzalez-Hernandez; Nicole M Iovine; Christiane E Wobus; Jan Vinjé; Scott A Tibbetts; Shannon M Wallet; Stephanie M Karst
Journal:  Science       Date:  2014-11-07       Impact factor: 47.728

6.  A single-amino-acid change in murine norovirus NS1/2 is sufficient for colonic tropism and persistence.

Authors:  Timothy J Nice; David W Strong; Broc T McCune; Calvin S Pohl; Herbert W Virgin
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

Review 7.  Norovirus immunology: Of mice and mechanisms.

Authors:  Kira L Newman; Juan S Leon
Journal:  Eur J Immunol       Date:  2015-08-25       Impact factor: 5.532

8.  Recovery of infectious murine norovirus using pol II-driven expression of full-length cDNA.

Authors:  Vernon K Ward; Christopher J McCormick; Ian N Clarke; Omar Salim; Christiane E Wobus; Larissa B Thackray; Herbert W Virgin; Paul R Lambden
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-20       Impact factor: 11.205

Review 9.  Host Genetic Susceptibility to Enteric Viruses: A Systematic Review and Metaanalysis.

Authors:  Anita Kambhampati; Daniel C Payne; Veronica Costantini; Benjamin A Lopman
Journal:  Clin Infect Dis       Date:  2015-10-26       Impact factor: 9.079

10.  An enteric virus can replace the beneficial function of commensal bacteria.

Authors:  Elisabeth Kernbauer; Yi Ding; Ken Cadwell
Journal:  Nature       Date:  2014-11-19       Impact factor: 49.962

View more
  127 in total

1.  Persistence of Systemic Murine Norovirus Is Maintained by Inflammatory Recruitment of Susceptible Myeloid Cells.

Authors:  Jacob A Van Winkle; Bridget A Robinson; A Mack Peters; Lena Li; Ruth V Nouboussi; Matthias Mack; Timothy J Nice
Journal:  Cell Host Microbe       Date:  2018-11-01       Impact factor: 21.023

2.  A Secreted Viral Nonstructural Protein Determines Intestinal Norovirus Pathogenesis.

Authors:  Sanghyun Lee; Hejun Liu; Craig B Wilen; Zoi E Sychev; Chandni Desai; Barry L Hykes; Robert C Orchard; Broc T McCune; Ki-Wook Kim; Timothy J Nice; Scott A Handley; Megan T Baldridge; Gaya K Amarasinghe; Herbert W Virgin
Journal:  Cell Host Microbe       Date:  2019-05-23       Impact factor: 21.023

3.  Nanobody-Mediated Neutralization Reveals an Achilles Heel for Norovirus.

Authors:  Anna D Koromyslova; Jessica M Devant; Turgay Kilic; Charles D Sabin; Virginie Malak; Grant S Hansman
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

4.  Avidity of α-fucose on human milk oligosaccharides and blood group-unrelated oligo/polyfucoses is essential for potent norovirus-binding targets.

Authors:  Franz-Georg Hanisch; Grant S Hansman; Vasily Morozov; Clemens Kunz; Horst Schroten
Journal:  J Biol Chem       Date:  2018-06-01       Impact factor: 5.157

5.  Tropism for tuft cells determines immune promotion of norovirus pathogenesis.

Authors:  Craig B Wilen; Sanghyun Lee; Leon L Hsieh; Robert C Orchard; Chandni Desai; Barry L Hykes; Michael R McAllaster; Dale R Balce; Taylor Feehley; Jonathan R Brestoff; Christina A Hickey; Christine C Yokoyama; Ya-Ting Wang; Donna A MacDuff; Darren Kreamalmayer; Michael R Howitt; Jessica A Neil; Ken Cadwell; Paul M Allen; Scott A Handley; Menno van Lookeren Campagne; Megan T Baldridge; Herbert W Virgin
Journal:  Science       Date:  2018-04-13       Impact factor: 47.728

6.  Viral Replication Complexes Are Targeted by LC3-Guided Interferon-Inducible GTPases.

Authors:  Scott B Biering; Jayoung Choi; Rachel A Halstrom; Hailey M Brown; Wandy L Beatty; Sanghyun Lee; Broc T McCune; Erin Dominici; Lelia E Williams; Robert C Orchard; Craig B Wilen; Masahiro Yamamoto; Jörn Coers; Gregory A Taylor; Seungmin Hwang
Journal:  Cell Host Microbe       Date:  2017-06-29       Impact factor: 21.023

Review 7.  The Dual Tropism of Noroviruses.

Authors:  Christiane E Wobus
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

8.  UFMylation inhibits the proinflammatory capacity of interferon-γ-activated macrophages.

Authors:  Dale R Balce; Ya-Ting Wang; Michael R McAllaster; Bria F Dunlap; Anthony Orvedahl; Barry L Hykes; Lindsay Droit; Scott A Handley; Craig B Wilen; John G Doench; Robert C Orchard; Christina L Stallings; Herbert W Virgin
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-05       Impact factor: 11.205

9.  Disruption of Type III Interferon (IFN) Genes Ifnl2 and Ifnl3 Recapitulates Loss of the Type III IFN Receptor in the Mucosal Antiviral Response.

Authors:  Stefan T Peterson; Elizabeth A Kennedy; Pamela H Brigleb; Gwen M Taylor; Kelly Urbanek; Traci L Bricker; Sanghyun Lee; Haina Shin; Terence S Dermody; Adrianus C M Boon; Megan T Baldridge
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

10.  Vesicle-Cloaked Virus Clusters Are Optimal Units for Inter-organismal Viral Transmission.

Authors:  Marianita Santiana; Sourish Ghosh; Brian A Ho; Vignesh Rajasekaran; Wen-Li Du; Yael Mutsafi; Dennise A De Jésus-Diaz; Stanislav V Sosnovtsev; Eric A Levenson; Gabriel I Parra; Peter M Takvorian; Ann Cali; Christopher Bleck; Anastasia N Vlasova; Linda J Saif; John T Patton; Patrizia Lopalco; Angela Corcelli; Kim Y Green; Nihal Altan-Bonnet
Journal:  Cell Host Microbe       Date:  2018-08-08       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.